Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

400
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seventh Åland Island Meeting on von Willebrand Disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Von Willebrand disease.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Analytical performance of the Roche Elecsys TnT hs Gen 6 immunoassay.

Clinical chemistry and laboratory medicine·2026
Same author

Intra-and Inter-Analyzer Imprecision of Cell Population Data on Sysmex XN-10.

EJIFCC·2026
Same author

The landmark contribution by Erik von Willebrand.

Haematologica·2026

Related Experiment Video

Updated: Feb 24, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.3K

Thrombin Generation Assays (TGAs).

Gian Luca Salvagno1, Erik Berntorp2

  • 1Section of Clinical Biochemistry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy. gianluca.salvagno@univr.it.

Methods in Molecular Biology (Clifton, N.J.)
|August 15, 2017
PubMed
Summary

Thrombin generation assays (TGAs) are reviving as a key tool to understand clotting. Newer TGAs offer better insights into hemostasis and potential for diagnosing bleeding disorders and guiding therapy.

Keywords:
CoagulationHemophiliaThrombin generation assay

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.9K

Related Experiment Videos

Last Updated: Feb 24, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.3K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.9K

Area of Science:

  • Coagulation science
  • Hemostasis research
  • Clinical laboratory diagnostics

Background:

  • Thrombin generation (TG) is central to hemostasis and thrombosis.
  • Traditional thrombin generation assays (TGAs) face limitations for clinical use due to reagent variability and technical constraints.
  • Recent advancements have led to newer TGAs with improved in vitro conditions.

Purpose of the Study:

  • To reinvestigate the balance of procoagulants and anticoagulants using advanced TGAs.
  • To assess the clinical utility of newer thrombin generation assays.
  • To explore the application of TGAs in diagnosing coagulopathies and monitoring therapy.

Main Methods:

  • Utilizing newer thrombin generation assays (TGAs) with continuous registration.
  • Employing in vitro conditions that closely mimic in vivo hemostasis.
  • Analyzing patient samples to evaluate hemostatic balance.

Main Results:

  • Newer TGAs provide a comprehensive assessment of overall hemostasis.
  • These advanced assays show promise for laboratory investigation of bleeding disorders.
  • TGAs can potentially monitor replacement therapy in various clinical settings.

Conclusions:

  • Thrombin generation assays are valuable research tools with renewed clinical potential.
  • Advancements in TGA technology enhance their diagnostic and therapeutic monitoring capabilities.
  • Improved TGAs offer a more accurate understanding of coagulation dynamics in patients.